Presence of Thrombin-Activatable Fibrinolysis Inhibitor in Helicobacter pylori-Associated Gastroduodenal Disease

被引:2
作者
Ikeda, Ayumi [2 ]
Gabazza, Esteban C. [1 ]
Morser, John [1 ]
Imoto, Ichiro [2 ]
Kuroda, Mikihito [2 ]
D'Alessandro-Gabazza, Corina N. [4 ]
Hara, Kenichiro
Ruiz, Daniel Boveda [1 ]
Bernabe, Paloma Gil [2 ]
Katsurahara, Masaki [2 ]
Toda, Masaaki [1 ]
Kobayashi, Yoshinao [2 ]
Yano, Yutaka [3 ]
Sumida, Yasuhiro [3 ]
Suzuki, Koji [5 ]
Taguchi, Osamu [4 ]
Takei, Yoshiyuki [2 ]
机构
[1] Mie Univ, Dept Immunol, Grad Sch Med, Tsu, Mie 5148507, Japan
[2] Mie Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Tsu, Mie 5148507, Japan
[3] Mie Univ, Dept Diabet & Endocrinol & Diabet, Grad Sch Med, Tsu, Mie 5148507, Japan
[4] Mie Univ, Dept Pulm & Crit Care Med, Grad Sch Med, Tsu, Mie 5148507, Japan
[5] Mie Univ, Dept Mol Pathobiol, Grad Sch Med, Tsu, Mie 5148507, Japan
关键词
coagulation; gastritis; ulcer; fibrinolysis; infection; GASTRIC-MUCOSA; CARBOXYPEPTIDASE-R; INFECTION; PATHOGENESIS; COAGULATION; DEPOSITION; RECEPTORS; PERITONITIS; EXPRESSION; MECHANISM;
D O I
10.1111/j.1523-5378.2009.00662.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Thrombin-activatable fibrinolysis inhibitor (TAFI) plays a role in the regulation of coagulation and inflammation. In addition to inhibiting the fibrinolytic system, TAFI may also regulate the bradykinin and complement systems. We hypothesized that TAFI also plays a role in defense mechanisms of the gastric mucosa during Helicobacter pylori infection. This study comprised 65 patients with gastroduodenal disorders: 41 patients with H. pylori infection, 13 without, and 11 patients with cured H. pylori infection. The gastric intramucosal concentrations of TAFI were measured by enzyme immunoassay. The gastric levels of TAFI and plasminogen activator inhibitor-1 were significantly increased in patients with H. pylori compared to those without infection or cured H. pylori. The presence of TAFI was detected in gastric mucosal epithelial cells. The concentration of TAFI was correlated with the degree of gastric mucosal atrophy, inflammation, and disease activity. These results show that TAFI is present in the gastric mucosa and that it may play a role in the pathogenesis of H. pylori infection-associated gastroduodenal disorders.
引用
收藏
页码:147 / 155
页数:9
相关论文
共 37 条
[1]  
AHRENHOLZ DH, 1980, SURGERY, V88, P41
[2]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[3]  
BAJZAR L, 2003, ARTERIOSCL THROM VAS, V20, P2511
[4]  
BERKOW RL, 1987, J IMMUNOL, V139, P3783
[5]   Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis [J].
Berstad, AE ;
Brandtzaeg, P ;
Stave, R ;
Halstensen, TS .
GUT, 1997, 40 (02) :196-203
[6]   Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N [J].
Campbell, WD ;
Lazoura, E ;
Okada, N ;
Okada, H .
MICROBIOLOGY AND IMMUNOLOGY, 2002, 46 (02) :131-134
[7]   Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection [J].
Colucci, M ;
Rossiello, MR ;
Pentimone, A ;
Berloco, P ;
Russo, F ;
Di Leo, A ;
Semeraro, N .
THROMBOSIS RESEARCH, 2005, 116 (06) :471-477
[8]   Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[9]   Gastric mucosal inflammatory responses to Helicobacter pylori [J].
Crabtree, JE .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 :29-37
[10]   Fibrin and fibrinolysis in infection and host defense [J].
Degen, J. L. ;
Bugge, T. H. ;
Goguen, J. D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :24-31